December 4-6th, 2018

Boston, MA

Grant McFadden

Grant McFadden, Center Director & Professor, Biodesign Center for Immunotherapy, ASU

Masataka Suzuki

Masataka Suzuki, Assistant Professor, Baylor College of Medicine

Brad Nelson

Brad Nelson, Director, Deeley Research Centre BC Cancer Agency

Frank Tufaro

Frank Tufaro, CEO, DNAtrix

Antonio Chiocca

Antonio Chiocca, Professor, Harvard Medical School

Faris Farassati

Faris Farassati, Associate Professor, University of Kansas Medical School

Angelica Loskog

Angelica Loskog, CEO, Lokon Pharma

Rachel Altura

Rachel Altura, Senior Medical Director,  Merck & Co.

Christophe Queva

Christophe Queva, Chief Scientific Officer, Oncorus

Steven Potts

Steven Potts, CEO, OncoMyx

Robert Coffin

Robert Coffin, CEO, Replimmune

Anna Cascante

Anna Cascante, Head of R&D, Sagetis Biotech

Magnus Jaderberg

Magnus Jaderberg, CMO, Targovax

Min Liang

Min Liang, CSO, TOT biopharma

Jose Manual Otero

José Manuel Otero, Vice President, CMC & Manufacturing, Turnstone Biologics

Daniel Katzman

Daniel Katzman, Chief Executive Officer, Unleash Immuno Oncolytics

OLYMPUS DIGITAL CAMERA

Stephen Thorne, Chief Scientific Officer, Western Oncolytics

William Jia

William Jia, Chief Scientific Officer, Virogen